科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ International journal of clinical pharmacology and therapeutics2026-08-25

Tranilast/roxithromycin with topical tacrolimus in refractory atopic facial eczema: Case report.

Yasuhiro Horiuchi

原始摘要(英文原文)· Original abstract
One challenge in atopic dermatitis is facial eczema, which requires delicate management because of the sensitive nature of facial skin. This report presents a 30-year-old male patient with facial eczema associated with atopic dermatitis, which could not be cured by conventional treatment, even with the continuation of oral betamethasone. The facial lesions were treated with pediatric 0.03% tacrolimus ointment. The patient was administered 200 mg/day tranilast and 300 mg/day roxithromycin. Within 3 weeks, his eczematous lesions on the face, as well as the severe itching, were completely cured. Addition of this combination therapy may be a promising therapeutic strategy for treating uncontrollable atopic dermatitis, particularly for facial eczema and itching.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

Tranilast/roxithromycin with topical tacrolimus in refractory atopic facial eczema: Case report. — 科研速览 Science Skim